Drugs Information: Tocilizumab
Basic Information
|
||
| ID | DDInter1824 | |
| Drug Type | biotech | |
| Molecular Formula | C6428H9976N1720O2018S42 | |
| Molecular Weight | - | |
| Description | Tocilizumab is an interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). | |
| ATC Classification | L04AC07 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Tocilizumab
| Severity level | ID | Name | Mechanism | Detail |
|---|